AIMS: Recent studies have provided increasing evidence that hepatocyte growth factor (HGF) has a pathophysiological role in the development of diabetic complications. We set out to determine the relationship between serum HGF and risk factors for macroangiopathy including carotid atherosclerosis. Carotid atherosclerosis is an established and important risk factor for both cerebral and coronary artery diseases. METHODS: We studied 89 patients (48 males, 41 females, mean age 62.5 +/- 10.3 years) with Type 2 diabetes (DM). RESULTS: Serum levels of HGF correlated positively with both intimal-media thickness (IMT) (r = 0.24, P = 0.0248) and plaque score (r = 0.27, P = 0.0126). In multiple regression analysis, serum HGF was associated independently with IMT (standardized beta = 0.28, P = 0.0499). We also found that both IMT and plaque score were higher in patients with ischaemic heart disease (IHD) than in patients without IHD, and that plaque score in patients with lacunar infarcts was higher than in patients without lacunar infarcts. CONCLUSIONS: Serum HGF concentration may be a new marker of atherosclerotic complications in patients with Type 2 DM.
AIMS: Recent studies have provided increasing evidence that hepatocyte growth factor (HGF) has a pathophysiological role in the development of diabetic complications. We set out to determine the relationship between serum HGF and risk factors for macroangiopathy including carotid atherosclerosis. Carotid atherosclerosis is an established and important risk factor for both cerebral and coronary artery diseases. METHODS: We studied 89 patients (48 males, 41 females, mean age 62.5 +/- 10.3 years) with Type 2 diabetes (DM). RESULTS: Serum levels of HGF correlated positively with both intimal-media thickness (IMT) (r = 0.24, P = 0.0248) and plaque score (r = 0.27, P = 0.0126). In multiple regression analysis, serum HGF was associated independently with IMT (standardized beta = 0.28, P = 0.0499). We also found that both IMT and plaque score were higher in patients with ischaemic heart disease (IHD) than in patients without IHD, and that plaque score in patients with lacunar infarcts was higher than in patients without lacunar infarcts. CONCLUSIONS: Serum HGF concentration may be a new marker of atherosclerotic complications in patients with Type 2 DM.
Authors: Swapnil N Rajpathak; Tao Wang; Sylvia Wassertheil-Smoller; Howard D Strickler; Robert C Kaplan; Aileen P McGinn; Rachel P Wildman; Daniel Rosenbaum; Thomas E Rohan; Philipp E Scherer; Mary Cushman; Gloria Y F Ho Journal: Stroke Date: 2010-03-04 Impact factor: 7.914
Authors: Suzette J Bielinski; Cecilia Berardi; Paul A Decker; Nicholas B Larson; Elizabeth J Bell; James S Pankow; Michele M Sale; Weihong Tang; Naomi Q Hanson; Christina L Wassel; Mariza de Andrade; Matthew J Budoff; Joseph F Polak; Hugues Sicotte; Michael Y Tsai Journal: Heart Date: 2017-06-01 Impact factor: 5.994
Authors: Yiwen Liu; Tao Wang; Jianyun Yan; Naomi Jiagbogu; Daniëlle A M Heideman; Ann E Canfield; M Yvonne Alexander Journal: Atherosclerosis Date: 2011-08-26 Impact factor: 5.162
Authors: Lucy Baldeón R; Karin Weigelt; Harm de Wit; Behiye Ozcan; Adri van Oudenaren; Fernando Sempértegui; Eric Sijbrands; Laura Grosse; Wilma Freire; Hemmo A Drexhage; Pieter J M Leenen Journal: PLoS One Date: 2014-12-12 Impact factor: 3.240